Skip to content

Clinical trials

Lymphoproliferative Disorders trials with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoproliferative Disorders Status: Unknown status Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20051
20101
20131
20172
20191
20201
20212
20223

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status13

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Assiut University1
Beijing Immunochina Medical Science & Technology Co., Ltd.1
Celularity Incorporated1
European Institute of Oncology1
Fairview University Medical Center1
Fudan University1
Hospices Civils de Lyon1
Hospital Israelita Albert Einstein1
Jonsson Comprehensive Cancer Center1
Medical University of Graz1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoproliferative Disorders13
Immune System Diseases3
Lymphoma3
Neoplasms3
Graft vs Host Disease2
Hematologic Diseases2
Immunoproliferative Disorders2
Lymphoma, Large B-Cell, Diffuse2
Lymphoma, Mantle-Cell2
Lymphoma, Non-Hodgkin2

Trials

Showing 26 to 13 of 13. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.